Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

New Solution for Kidney Stones—Take a Roller Coaster Ride!

By Kenny Walter | October 12, 2016

Thrill-seekers and theme park aficionados have a better chance to rid themselves of painful kidney stones, according to a new study.

The research in the October issue of The Journal of American Osteopathic Association concludes that riding a moderate-intensity roller coaster can help people pass smaller kidney stones with a nearly 70-percent success rate.

David Wartinger, a professor emeritus in the Department of Osteopathic Surgical Specialties at Michigan
State University (MSU), led both a pilot study and an expanded study to assess whether the stories he was hearing from patients were true.

“Basically, I had patients telling me that after riding a particular roller coaster at Walt Disney World, they were able to pass their kidney stone,” Wartinger said in a statement. “I even had one patient say he passed three different stones after riding multiple times.”

Wartinger used a validated, synthetic 3D model of a hollow kidney with three kidney stones smaller than 4 mm in a backpack on Big Thunder Mountain Railroad at Disney World 20 times to verify patient reports that the roller coaster helped dislodge kidney stones.

“In the pilot study, sitting in the last car of the roller coaster showed about a 64 percent passage rate, while sitting in the first few cars only had a 16 percent success rate,” Wartinger said.

Wartinger then expanded the study with Mark Mitchell, an MSU resident at the time, and concluded that riding the same roller coaster in the back produced a passage rate of nearly 70 percent. The study also showed a 100 percent passage rate if the stones were located in the upper chamber of the kidney.

“In all, we used 174 kidney stones of varying shapes, sizes and weights to see if each model worked on the same ride and on two other roller coasters,” Wartinger added. “Big Thunder Mountain was the only one that worked.”

According to Wartinger, both Space Mountain and Aerosmith’s Rock n’ Roller Coaster failed to produce positive results because they were too fast and too violent with a G-force that pins the stone into the kidney and doesn’t allow it to pass.

Big Thunder Mountain Railroad has twin tubular steel rails and does not go upside down. The maximum speed is 35 mph and the model was subjected to sharp turns and quick drops during the ride, which lasted two minutes and 30 seconds.

In the United States each year, more than 300,000 patients seek emergency department care for kidney stones, or renal calculi, with treatment costing between $5,000 and $10,000.

While the study focused on Disney World, the majority of the country lives within driving distance to an amusement park with a ride of similar intensity to Big Thunder Mountain Railroad. However, physicians and their patients should consider renal calculi location and size as well as medical history.

“You need to heed the warnings before going on a roller coaster,” Wartinger concluded. “If you have a kidney stone, but are otherwise healthy and meet the requirements of the ride, patients should try it. It’s definitely a lower-cost alternative to healthcare.”

Table 1.

Passage of Renal Calculi in a Functional Pyelocalyceal Renal Model Placed in Front Section of Roller Coastera

Location of Calculi in Calyx

Calculi Volume

Overall Passage

4.5 mm3

13.5 mm3

64.6 mm3

    Upper

0/1 (0)

0/1 (0)

2/7 (28.6)

2/9 (22.2)

    Middle

0/4 (0)

1/2 (50.0)

…

1/6 (16.7)

    Lower

1/3 (33.3)

0/5 (0)

0/1 (0)

1/9 (11.1)

    Total

1/8 (12.5)

1/8 (12.5)

2/8 (25.0)

4/24 (16.7)

a Data are given as No. passed/No. of attempts (%).

View Large

Table 2.

Passage of Renal Calculi in a Functional Pyelocalyceal Renal Model Placed in Rear Section of Roller Coastera

Location of Calculi in Calyx

Calculi Volume

Overall Passage

4.5 mm3

13.5 mm3

64.6 mm3

    Upper

4/4 (100)

4/4 (100)

4/4 (100)

12/12 (100)

    Middle

3/3 (100)

1/4 (25.0)

1/2 (50.0)

5/9 (55.6

    Lower

1/5 (20.0)

2/4 (50.0)

3/6 (50.0)

6/15 (40.0)

    Total

8/12 (66.7)

7/12 (58.3)

8/12 (66.7)

23/36 (63.9)

Source: The Journal of the American Osteopathic Association

 

 

 

 

Related Articles Read More >

Drones help diagnose deadly whale viruses 
Drowning in variants? Mount Sinai tool adds phenotype filter
Oral Wegovy approval charts a new course for blockbuster drug development
Los Alamos’ R&D 100-winning EpiEarth platform helps predict the global outbreaks early
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE